Kona Medical
Renal denervation isn’t dead, despite Medtronic trial’s failure
Kona Medical launches hypertension trial for non-invasive RDN device
Kona Medical said this week that it’s launched a clinical trial of the non-invasive renal denervation device for treating hypertension it calls Surround Sound.
Kona Medical raises $10M Series D
Kona Medical said it closed a $10 million Series D round it plans to use to enter the Chinese renal denervation market.
Unlike other renal ablation systems, Kona’s Surround Sound device uses external ultrasound to non-invasively target the nerves leading to and from the kidney.
Funding: Non-invasive renal ablation tech firm Kona Medical closes $40M Series C
Hypertension treatment devices maker Kona Medical closed a Series C funding round totaling $40 million in support of its ultrasound-based renal ablation systems.
Unlike other renal ablation systems, Kona’s Surround Sound device uses external ultrasound to non-invasively target the nerves leading to and from the kidney, according to a press release.
